163 related articles for article (PubMed ID: 10945505)
21. Bcl-xL is phosphorylated in malignant cells following microtubule disruption.
Poruchynsky MS; Wang EE; Rudin CM; Blagosklonny MV; Fojo T
Cancer Res; 1998 Aug; 58(15):3331-8. PubMed ID: 9699663
[TBL] [Abstract][Full Text] [Related]
22. Laulimalide and paclitaxel: a comparison of their effects on tubulin assembly and their synergistic action when present simultaneously.
Gapud EJ; Bai R; Ghosh AK; Hamel E
Mol Pharmacol; 2004 Jul; 66(1):113-21. PubMed ID: 15213302
[TBL] [Abstract][Full Text] [Related]
23. New microtubule/tubulin-targeted anticancer drugs and novel chemotherapeutic strategies.
Wilson L; Jordan MA
J Chemother; 2004 Nov; 16 Suppl 4():83-5. PubMed ID: 15688618
[TBL] [Abstract][Full Text] [Related]
24. Interaction of brain cytoplasmic dynein and MAP2 with a common sequence at the C terminus of tubulin.
Paschal BM; Obar RA; Vallee RB
Nature; 1989 Nov; 342(6249):569-72. PubMed ID: 2531294
[TBL] [Abstract][Full Text] [Related]
25. βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.
Smiyun G; Azarenko O; Miller H; Rifkind A; LaPointe NE; Wilson L; Jordan MA
Cancer Chemother Pharmacol; 2017 Jul; 80(1):151-164. PubMed ID: 28567478
[TBL] [Abstract][Full Text] [Related]
26. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
27. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
[TBL] [Abstract][Full Text] [Related]
28. Microtubule-associated parameters as predictive markers of docetaxel activity in advanced breast cancer patients: results of a pilot study.
Bernard-Marty C; Treilleux I; Dumontet C; Cardoso F; Fellous A; Gancberg D; Bissery MC; Paesmans M; Larsimont D; Piccart MJ; Di Leo A
Clin Breast Cancer; 2002 Dec; 3(5):341-5. PubMed ID: 12533264
[TBL] [Abstract][Full Text] [Related]
29. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
Rosenblum MD; Shivers RR
Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
[TBL] [Abstract][Full Text] [Related]
30. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
[TBL] [Abstract][Full Text] [Related]
31. Assessment of microtubule stabilizers by semiautomated in vitro microtubule protein polymerization and mitotic block assays.
Lopes NM; Miller HP; Young ND; Bhuyan BK
Cancer Chemother Pharmacol; 1997; 41(1):37-47. PubMed ID: 9443612
[TBL] [Abstract][Full Text] [Related]
32. [Taxoids: structural and experimental properties].
Lavelle F; Combeau C; Commerçon A
Bull Cancer; 1995 Apr; 82(4):249-64. PubMed ID: 10846536
[TBL] [Abstract][Full Text] [Related]
33. Anti-tumour activity of a panel of taxanes toward a cellular model of human cervical cancer.
Gallo D; Ferlini C; Distefano M; Cantelmo F; Gaggini C; Fattorossi A; Riva A; Bombardelli E; Proietti E; Mancuso S; Scambia G
Cancer Chemother Pharmacol; 2000; 45(2):127-32. PubMed ID: 10663627
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of water-soluble non-prodrug analogs of docetaxel bearing sec-aminoethyl group at the C-10 position.
Uoto K; Takenoshita H; Yoshino T; Hirota Y; Ando S; Mitsui I; Terasawa H; Soga T
Chem Pharm Bull (Tokyo); 1998 May; 46(5):770-6. PubMed ID: 9621410
[TBL] [Abstract][Full Text] [Related]
35. Semi-synthesis of an O-glycosylated docetaxel analogue.
Nikolakakis A; Haidara K; Sauriol F; Mamer O; Zamir LO
Bioorg Med Chem; 2003 Apr; 11(7):1551-6. PubMed ID: 12628678
[TBL] [Abstract][Full Text] [Related]
36. Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain.
Gong CX; Wegiel J; Lidsky T; Zuck L; Avila J; Wisniewski HM; Grundke-Iqbal I; Iqbal K
Brain Res; 2000 Jan; 853(2):299-309. PubMed ID: 10640627
[TBL] [Abstract][Full Text] [Related]
37. Characterization and intracellular distribution of microtubule-associated protein 2 in differentiating human neuroblastoma cells.
Kirsch J; Zutra A; Littauer UZ
J Neurochem; 1990 Sep; 55(3):1031-41. PubMed ID: 1696615
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous combination of microtubule depolymerizing and stabilizing agents acts at low doses.
Garcia P; Braguer D; Carles G; Briand C
Anticancer Drugs; 1995 Aug; 6(4):533-44. PubMed ID: 7579557
[TBL] [Abstract][Full Text] [Related]
39. The effect of stathmin phosphorylation on microtubule assembly depends on tubulin critical concentration.
Amayed P; Pantaloni D; Carlier MF
J Biol Chem; 2002 Jun; 277(25):22718-24. PubMed ID: 11956188
[TBL] [Abstract][Full Text] [Related]
40. MAC-321, a novel taxane with greater efficacy than paclitaxel and docetaxel in vitro and in vivo.
Sampath D; Discafani CM; Loganzo F; Beyer C; Liu H; Tan X; Musto S; Annable T; Gallagher P; Rios C; Greenberger LM
Mol Cancer Ther; 2003 Sep; 2(9):873-84. PubMed ID: 14555706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
